ORMP ORAMED PHARMACEUTICALS INC Expansion Plans 8-K Filing 2024 - Securities Agreement Oramed Pharmaceuticals Inc. entered into a securities purchase agreement with Scilex Holding Company, involving a $101.875 million promissory note and warrants for shares, and refinanced part of this debt with a new $50 million tranche of convertible notes and additional warrants, while also acquiring rights to 4% of net sales from certain products for $5 million.Get access to all SEC 8-K filings of the ORAMED PHARMACEUTICALS INC